OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Vikram Thakur, Shivam Bhola, Pryanka Thakur, et al.
Infection (2021) Vol. 50, Iss. 2, pp. 309-325
Open Access | Times Cited: 169

Showing 51-75 of 169 citing articles:

An Exploration of Nanoparticle-Based Diagnostic Approaches for Coronaviruses: SARS-CoV-2, SARS-CoV and MERS-CoV
Ahmed Al-Hindawi, Usama AlDallal, Yousef M. Waly, et al.
Nanomaterials (2022) Vol. 12, Iss. 20, pp. 3550-3550
Open Access | Times Cited: 11

Exposure factors associated with SARS-CoV-2 seroprevalence during the first eight months of the COVID-19 pandemic in the Netherlands: A cross-sectional study
Demi M. E. Pagen, Stephanie Brinkhues, Nicole H. T. M. Dukers–Muijrers, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0268057-e0268057
Open Access | Times Cited: 10

Contrasting Epidemiology and Population Genetics of COVID-19 Infections Defined by Multilocus Genotypes in SARS-CoV-2 Genomes Sampled Globally
Felicia Hui Min Chan, Ricardo Ataíde, Jack S. Richards, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1434-1434
Open Access | Times Cited: 10

Seroprevalence of COVID-19 infection in a densely populated district in the eastern Democratic Republic of Congo
Léonid M. Irenge, Homer M. Bulakali, Arthur Irenge Akonkwa, et al.
Epidemiology and Infection (2023) Vol. 151
Open Access | Times Cited: 6

COVID-19-Related Age Profiles for SARS-CoV-2 Variants in England and Wales and States of the USA (2020 to 2022): Impact on All-Cause Mortality
Rod Jones, Andrey Ponomarenko
Infectious Disease Reports (2023) Vol. 15, Iss. 5, pp. 600-634
Open Access | Times Cited: 6

A Comparison of Ivermectin and Non Ivermectin Based Regimen for COVID-19 in Abuja: Effects on Virus Clearance, Days-to-discharge and Mortality
Thairu Yunusa, Olawale Babalola, A. A. Ajayi, et al.
Journal of Pharmaceutical Research International (2022), pp. 1-19
Open Access | Times Cited: 9

The amount of SARS-CoV-2 RNA in wastewater relates to the development of the pandemic and its burden on the health system
Hao Wang, Marianela Patzi Churqui, Timur Tunovic, et al.
iScience (2022) Vol. 25, Iss. 9, pp. 105000-105000
Open Access | Times Cited: 9

Post-acute COVID syndrome (long COVID): What should radiographers know and the potential impact for imaging services
Fahad Alghamdi, Rebecca Owen, Ruth Ashton, et al.
Radiography (2022) Vol. 28, pp. S93-S99
Open Access | Times Cited: 9

SARS-CoV-2 S Mutations: A Lesson from the Viral World to Understand How Human Furin Works
Leonardo Cassari, Angela Pavan, Giulia Zoia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4791-4791
Open Access | Times Cited: 5

Epidemiological Surveillance Reveals the Rise and Establishment of the Omicron SARS-CoV-2 Variant in Brazil
Joice do Prado Silva, Aline Brito de Lima, Luige Biciati Alvim, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 1017-1017
Open Access | Times Cited: 5

Differences in Trends in Admissions and Outcomes among Patients from a Secondary Hospital in Madrid during the COVID-19 Pandemic: A Hospital-Based Epidemiological Analysis (2020–2022)
Rafael García Carretero, Óscar Vázquez-Gómez, María Ordoñez-Garcia, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1616-1616
Open Access | Times Cited: 5

A Comprehensive Analysis of Structural and Functional Changes Induced by SARS-CoV-2 Spike Protein Mutations
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
COVID (2023) Vol. 3, Iss. 9, pp. 1454-1472
Open Access | Times Cited: 5

Gag Virus-like Particles Functionalized with SARS-CoV-2 Variants: Generation, Characterization and Recognition by COVID-19 Convalescent Patients’ Sera
Arnau Boix‐Besora, Francesc Gòdia, Laura Cervera
Vaccines (2023) Vol. 11, Iss. 11, pp. 1641-1641
Open Access | Times Cited: 5

The Differentiation and Maintenance of SARS-CoV-2-Specific Follicular Helper T Cells
Yifei Wang, Qin Tian, Lilin Ye
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 8

SARS-CoV-2 variants of concern: a review
Malay Sarkar, Irappa Madabhavi
Monaldi Archives for Chest Disease (2022)
Open Access | Times Cited: 8

Changing characteristics of post-COVID-19 syndrome: Cross-sectional findings from 458 consultations using the Stanford Hall remote rehabilitation assessment tool
Andrew Houston, C Tovey, Kasha Rogers-Smith, et al.
BMJ Military Health (2023) Vol. 170, Iss. 6, pp. 477-483
Open Access | Times Cited: 4

Spread of Pathogens Causing Respiratory Viral Diseases Before and During CoVID-19 Pandemic in Kazakhstan
N. G. Klivleyeva, G. V. Lukmanova, Т. И. Глебова, et al.
Indian Journal of Microbiology (2023) Vol. 63, Iss. 1, pp. 129-138
Open Access | Times Cited: 4

A comparative analysis of the second and third wave of the Covid-19 pandemic: an experience from a tertiary care hospital in Western India
Anjali Swami, Ankita Mohanty, Ashima Jamwal, et al.
Journal of Medical Microbiology (2023) Vol. 72, Iss. 5
Closed Access | Times Cited: 4

A Noble Extract of Pseudomonas sp. M20A4R8 Efficiently Controlling the Influenza Virus-Induced Cell Death
Subin Jung, Grace Choi, Hyo‐Jin Kim, et al.
Microorganisms (2024) Vol. 12, Iss. 4, pp. 677-677
Open Access | Times Cited: 1

APOBEC3-related mutations in the spike protein-encoding region facilitate SARS-CoV-2 evolution
Jiaying Shen, Xinxin Xu, Junyan Fan, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32139-e32139
Open Access | Times Cited: 1

In silico screening and evaluation of antiviral peptides as inhibitors against ORF9b protein of SARS-CoV-2
Gaurav Kumar Sharma, Prateek Paul, Ananya Dviwedi, et al.
3 Biotech (2024) Vol. 14, Iss. 9
Closed Access | Times Cited: 1

Variant-specific neutralising antibodies levels induced by the PHH-1 V SARS-CoV-2 vaccine (Bimervax®) by HIPRA
Anna England, Julia Sung, Meritxell Deulofeu, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126386-126386
Open Access | Times Cited: 1

Scroll to top